Innovation Without the Overheads – Why Abingdon Attracts Start-ups and Scale-ups
Mark Hanna, Country Lead Asset Management – UK & Ireland, on Abingdon’s attractive business ecosystem
Abingdon Science Park just south of Oxford has become a magnet for high-potential start-ups and scale-ups
Abingdon Science Park, located just south of Oxford, has become a magnet for high-potential startups and scaleups — and it’s easy to see why. Here, companies can access purpose-built laboratory and technical workspace, designed with growth in mind. It’s part of a new wave of science-led real estate that supports businesses graduating from the incubation phase into scalable, standalone operations. This transition is a critical moment in a company’s journey – it’s where scientific ambition meets commercial execution. Having the right environment, tailored to technical needs but flexible enough to scale, can make the difference between plateauing and accelerating growth.
Take Alethio Therapeutics, a pioneer in precision antenna technology that’s vital to autonomous systems, and Medimab Biotherapeutics, a cutting-edge biopharmaceutical firm developing antibodies for autoimmune disease. Both companies began life in the Oxford Bioescalator, one of the UK’s premier life science incubators. When the time came to expand, they chose Abingdon Science Park — recognising it as the natural next stage in their growth journey.
Why? Because Abingdon offers more than just space. It offers the right kind of space: cost-effective, technically capable, and with flexible terms that reflect the ups and downs of scientific progress. Whether it’s enhanced M&E systems, a dedicated lab & building manager on site, lab-enabled units, or power resilience, the infrastructure here is built for science — and it’s ready to go.
For founders managing grant cycles, investment milestones, and evolving team sizes, that flexibility is key. So too is affordability. Unlike central Oxford, London or Cambridge, where costs can quickly outpace budgets, Abingdon delivers value — allowing startups to reinvest in talent, technology, and IP development instead of overheads.
Location is another advantage.
Abingdon is just 20 minutes from Oxford, keeping companies within reach of university collaboration, venture capital, and academic talent — without the pressure of city centre constraints. And with a growing network of peers on-site, from biotech to quantum technologies, companies benefit from a supportive, multidisciplinary community.
At its heart, Abingdon Science Park supports a new kind of growth story — one that doesn’t rely on compromise. For Alethio Therapeutics and Medimab Biotherapeutics, the move from incubator to independent space has meant accelerating R&D, growing their teams, and accessing the resources they need — all without the heavy burden of big-city costs.
For landlords and real estate developers, there’s a clear takeaway: innovation ecosystems thrive where buildings are designed around the needs of their tenants. In Abingdon, this principle is proving itself time and again — helping companies scale science into real-world impact, sustainably and successfully.
Because when you remove the overheads, innovation has room to breathe — and to thrive.
Stay ahead in science and innovation
Subscribe for updates from the Kadans community.
